Skip to main content
Clinical Trials/CTRI/2017/08/009401
CTRI/2017/08/009401
Recruiting
Phase 3

Study of the evaluation of postoperative analgesia after modified radical mastectomy by surgical site infiltration with either Bupivacaine alone or with Dexmedetomidine

Monisha B J Neelankavil0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- breast cancer
Sponsor
Monisha B J Neelankavil
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Monisha B J Neelankavil

Eligibility Criteria

Inclusion Criteria

  • breast cancer patients undergoing modified radical mastectomy

Exclusion Criteria

  • Known hypersensitivity or contraindication to Bupivacaine or Dexmedetomidine; pregnancy, drug allergy, cardiac patients, renal patients, significant pulmonary diseases, bleeding diathesis, psychological, neurological, metabolic diseases,Chronic analgesic drug abuse (on oral analgesics for more than a month).

Outcomes

Primary Outcomes

Not specified

Similar Trials